Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats

Journal of Ethnopharmacology

Volumn 110, Issue 2, 2007, Pages 311-317

  Nakagawa, Takako ^a   Goto, Hirozo ^a   Hikiami, Hiroaki ^a   Yokozawa, Takako ^a   Shibahara, Naotoshi ^a   Shimada, Yutaka ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Diabetic nephropathy; Fibronectin; Keishibukuryogan; Transforming growth factor 1 (TGF 1); WBN Kob rat

Indexed keywords

8 HYDROXY DEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; FIBRONECTIN; GLUCOSE; INSULIN; KEISHI BUKURYO GAN; PAEONIA RADIX; PLANT EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CINNAMON; CIRCULATION; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; KIDNEY MASS; LIPID PEROXIDATION; LIVER WEIGHT; MALE; MEDICINAL PLANT; NONHUMAN; OXIDATIVE STRESS; PAEONIA SUFFRUTICOSA; PERSICAE SEMEN; PORIA; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; URINARY EXCRETION;

ANIMALS; BLOOD GLUCOSE; CREATININE; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DRUGS, CHINESE HERBAL; FIBRONECTINS; HYPERGLYCEMIA; KIDNEY; LIPID PEROXIDATION; MALE; MEDICINE, TRADITIONAL; ORGAN SIZE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT PREPARATIONS; PROTECTIVE AGENTS; PROTEINURIA; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1; WEIGHT LOSS;

CINNAMOMI; PORIA; RATTUS;

EID: 33847165208     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.09.043     Document Type: Article

References (43)

1. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
2. Cooper M.E. Pathogenesis, prevention and treatment of diabetic nephropathy. Lancet 352 (1998) 213-219
3. Craven P.A., DeRubertis F.R., Kagan V.E., Melhem M., and Studer R.K. Effects of supplementation with Vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. Journal of the American Society of Nephrology 8 (1997) 1405-1414
4. Derubertis F.R., and Craven P.A. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43 (1994) 1-8
5. Fumo P., Kuncio G.S., and Ziyadeh F.N. PKC and high glucose stimulate collagen α1 (IV) transcriptional activity in a reporter mesangial cell line. The American Journal of Physiology 267 (1994) F632-F638
6. Giugliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19 (1996) 257-267
7. Goto H., Shimada Y., Sekiya N., Yang Q., Kogure T., Mantani N., Hikiami H., Shibahara N., and Terasawa K. Effects of Keishi-bukuryo-gan on vascular function and hemorrheological factors in spontaneously diabetic (WBN/Kob) rats. Phytomedicine 11 (2004) 188-195
8. Ha H., and Kim K.H. Role of oxidative stress in the development of diabetic nephropathy. Kidney International 51 (1995) s18-s21
9. 1, its type II receptor, and activation of the smad signaling pathway in the db/db mouse. American Journal of Pathology 158 (2001) 1653-1663
10. Ignotz R.A., Endo T., and Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. The Journal of Biological Chemistry 262 (1987) 6443-6446
11. Ishizaki M., Masuda Y., Fukuda Y., Yamanaka N., Masugi Y., Shichinohe K., and Nakama K. Renal lesions in a strain of spontaneously diabetic WBN/Kob rats. Acta Diabetologica Latina 24 (1987) 27-35
12. Itzhaki R.F., and Gill D.M. A micro-biuret method for estimating proteins. Analytical Biochemistry 9 (1964) 401-410
13. Kakimoto M., Inoguchi T., Sonta T., Yu H.Y., Imamura M., Etoh T., Hashimoto T., and Nawata H. Accumulation of 8-hydroxy-2′-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 51 (2002) 1588-1595
14. Kasahara Y., Goto H., Shimada Y., Sekiya N., Yang Q., and Terasawa K. Effects of keishi-bukuryo-gan on endothelial function in spontaneously hypertensive rats. Journal of Traditional Medicines 18 (2001) 113-118
15. Koya D., Lee I.K., Ishii H., Kanoh H., and King G.L. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocophenol. Journal of the American Society of Nephrology 8 (1997) 426-435
16. Matsumoto K., and Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney International 59 (2001) 2023-2038
17. Mauer S.M., Steffes M.W., Ellis E.N., Sutherland D.E., Brown D.M., and Goetz F.C. Structural-functional relationships in diabetic nephropathy. The Journal of Clinical Investigation 74 (1984) 1143-1155
18. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry 86 (1978) 271-278
19. 1 production by HGF in attenuation of murine diabetic nephropathy. American Journal of Physiology: Renal Physiology 286 (2004) F134-F143
20. Mogensen C.E. Diabetic renal disease in patients with type 2 diabetes mellitus: new strategies for prevention and treatment. Treatments in Endocrinology 1 (2002) 3-11
21. Mori Y., Yokoyama J., Nishimura M., Oka H., Mochio S., and Ikeda Y. Development of diabetic complications in a new diabetic strain of rat (WBN/Kob). Pancreas 7 (1992) 569-577
22. Naito C., and Yamanaka T. Lipid peroxides in atherosclerotic diseases. Japanese Journal of Geriatrics 15 (1978) 187-191
23. Nakagawa T., Yokozawa T., and Terasawa K. A study of Kampo medicines in a diabetic nephropathy model. Journal of Traditional Medicines 18 (2001) 161-168
24. Nakagawa T., Yokozawa T., Terasawa K., and Nakanishi K. Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy. Journal of Pharmacy and Pharmacology 55 (2003) 219-227
25. Nakagawa T., Yokozawa T., Oowada S., Goto H., Shibahara N., Shimada Y., and Terasawa K. Amelioration of kidney damage in spontaneously diabetic WBN/Kob rats after treatment with Keishi-bukuryo-gan. Journal of Traditional Medicines 20 (2003) 156-164
26. Nath K.A., Grande J., Croatt A., Haugen J., Kim Y., and Rosenberg M.E. Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression. Kidney International 53 (1998) 367-381
27. Nishioka I. Chemistry and biological activities of tannins. Journal of the Pharmaceutical Society of Japan 103 (1983) 125-142
28. Perico N., Codreanu I., Schieppati A., and Remuzzi G. Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago?. Kidney International 98 (2005) S21-S24
29. Ritz E., and Orth S.R. Nephropathy in patients with type 2 diabetes mellitus. New England Journal of Medicine 341 (1999) 1127-1133
30. Sato Y., Hotta N., Sakamoto N., Matsuoka S., Ohishi N., and Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochemical Medicine 21 (1979) 104-107
31. Sekiya N., Tanaka N., Itoh T., Shimada Y., Goto H., and Terasawa K. Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit. Phytotherapy Research 13 (1999) 192-196
32. Sharma K., and Ziyadeh F.N. Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-β as a key mediator. Diabetes 44 (1995) 1139-1146
33. Singh R., Song R.H., Alavi N., Pegoraro A.A., Singh A.K., and Leehey D.J. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1. Experimental Nephrology 9 (2001) 249-257
34. Steffes M.W., Osterby R., Chavers B., and Mauer S.M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38 (1989) 1077-1081
35. Trachtman H. Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvascular Research 47 (1994) 232-239
36. Trachtman H., Futterweit S., and Bienkowski R.S. Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochemical Biophysical Research Communications 191 (1993) 759-765
37. Trachtman H., Futterweit S., Maesaka J., Ma C., Valderrama E., Fuchs A., Tarectecan A.A., Rao P.S., Sturman J.A., Boles T.H., Fu M., and Baynes J. Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. The American Journal of Physiology 269 (1995) F429-F438
38. Vlassara H., Striker L.J., Teichberg S., Fuh H., Li Y.M., and Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proceedings of the National Academy of Science of the United States of America 91 (1994) 11704-11708
39. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacological Reviews 50 (1998) 21-33
40. Yokozawa T., Dong E., Liu Z.W., and Oura H. Antiperoxidation activity of traditional Chinese prescriptions and their main crude drugs in vitro. Natural Medicines 51 (1997) 92-97
41. Yokozawa T., Chen C.P., and Liu Z.W. Effect of traditional Chinese prescriptions and their main crude drugs on 1,1-diphenyl-2-picrylhydrazyl radical. Phytotherapy Research 12 (1998) 94-97
42. Yoshikawa H., Kihara Y., Taguchi M., Yamaguchi T., Nakamura H., and Otsuki M. Role of TGF-β1 in the development of pancreatic fibrosis in Otsuka Long-Evans Tokushima fatty rats. The American Journal of Physiology 282 (2002) G549-G558
43. Ziyadeh F.N., Sharma K., Ericksen M., and Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. The Journal of Clinical Investigation 3 (1994) 536-542